Ledger.Open graph →
SEC Form D · filed January 20, 2021

Enveric Biosciences, Inc

Offering
$8.2M
Sold
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NAPLES, FL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Avani Kanubaddi · Naples, FLExecDavid Johnson · Naples, FLExec · DirectorJohn Van Buiten · Naples, FLExecMarcus Schabacker · Naples, FLDirectorGeorge Kegler · Naples, FLDirectorSol Mayer · Naples, FLDirectorMark Lee · New York, NYDirectorTodd A. Wyatt · Royal Oak, MIExec · DirectorScott A. Fine · Westport, CTDirectorRobert J. Moser · Saratoga Springs, NYExecGenevieve Gilbreath · Austin, TXExecBrian Blagg · Indianapolis, INDirectorRalph N. Strayhorn, Iii · Charlotte, NCExec · DirectorRonan Guilfoyle · George Town, Grand Cayman, Cayman IslandsExecMaureen Z. Offer · Menlo Park, CADirectorThomas J. Bartos · Independence, OHDirectorGary A. Zdolshek · Independance, OHExecGarrett E. Zdolshek · Independence, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗